T1	Species 46 50	mice
T2	Sex 201 205	male
T3	Species 206 210	mice
T4	Species 239 243	mice
T5	Species 294 298	mice
T6	Species 391 395	mice
T7	GroupName 676 689	control group
T8	GroupName 694 712	three noise groups
T9	Dose 783 785	95
T10	TestArticle 764 779	broadband noise
T11	DoseUnits 786 823	decibel sound pressure level (dB SPL)
T14	DoseFrequency 884 891	20 days
T15	GroupName 893 903	N20D group
T16	DoseDuration 906 908	10
T17	DoseDurationUnits 909 913	days
T18	DoseFrequency 828 840	4 hr per day
T12	GroupName 915 925	N10D group
T13	GroupName 938 947	N1D group
T19	DoseDurationUnits 933 936	day
T20	DoseDuration 931 932	1
T21	TimeEndpointAssessed 1108 1113	1 day
T22	TimeEndpointAssessed 1115 1121	1 week
T23	TimeEndpointAssessed 1127 1134	1 month
T24	TimeEndpointAssessed 1167 1171	1DPN
T25	TimeEndpointAssessed 1173 1177	1WPN
T26	TimeEndpointAssessed 1183 1187	1MPN
T27	Species 1208 1212	mice
T28	GroupName 1220 1233	control group
T29	GroupName 1745 1762	the control group
T30	GroupName 1767 1785	three noise groups
T32	DoseDuration 1846 1848	10
T33	DoseFrequency 1860 1864	days
T31	DoseDuration 1826 1828	20
T34	DoseDurationUnits 1840 1844	days
T35	DoseDuration 1869 1870	1
T36	DoseDurationUnits 1871 1874	day
T37	GroupName 1894 1898	N20D
T38	GroupName 1900 1904	N10D
T39	GroupName 1910 1913	N1D
T40	GroupName 2094 2107	control group
T41	GroupName 2147 2151	N10D
T42	GroupName 2156 2159	N1D
T46	Endpoint 2365 2383	glucose metabolism
T47	TimeEndpointAssessed 2573 2577	1DPN
T48	TimeEndpointAssessed 2579 2583	1WPN
T49	TimeEndpointAssessed 2589 2593	1MPN
T50	Endpoint 2628 2648	β-cell proliferation
T51	Species 2654 2658	mice
T52	Species 2892 2896	mice
T53	GroupName 2822 2825	N1D
T54	TimeEndpointAssessed 2514 2515	1
T55	TimeUnits 2516 2519	day
T43	TimeEndpointAssessed 2521 2522	1
T56	TimeUnits 2523 2527	week
T44	TimeEndpointAssessed 2533 2534	1
T57	TimeUnits 2535 2540	month
T45	Dose 2986 2988	95
T58	DoseDurationUnits 2989 2995	dB SPL
T59	DoseFrequency 3000 3012	4 hr per day
T60	Endpoint 3105 3113	diabetes
T61	DoseDuration 2112 2114	20
T62	DoseDurationUnits 2115 2119	days
T63	Endpoint 3955 3988	Auditory Brainstem Response (ABR)
T64	TimeEndpointAssessed 4052 4056	1DPN
T65	Endpoint 4034 4037	ABR
T66	Endpoint 4322 4325	ABR
T67	Endpoint 4493 4510	glucose tolerance
T68	Species 4573 4577	mice
T69	Endpoint 4721 4740	blood glucose level
T70	Endpoint 4848 4867	serum insulin level
T71	Endpoint 5006 5019;5038 5044	blood glucose levels
T72	Endpoint 5024 5044	serum insulin levels
T73	Endpoint 5210 5223	blood glucose
T74	Endpoint 5247 5260	serum insulin
T75	Endpoint 5402 5415;5434 5440	blood glucose levels
T76	Endpoint 5420 5440	serum insulin levels
T77	Endpoint 5611 5629	insulin resistance
T78	GroupName 5829 5838	N1D group
T79	GroupName 5847 5854	control
T80	Endpoint 5858 5875	glucose tolerance
T81	Endpoint 5880 5896	insulin response
T82	TimeEndpointAssessed 5900 5904	1WPN
T83	GroupName 5951 5960	N1D group
T84	TimeEndpointAssessed 5964 5968	1MPN
T85	Endpoint 5910 5926	insulin response
T86	Endpoint 4446 4463	Glucose Tolerance
T87	Endpoint 5987 6004	Insulin Tolerance
T88	Species 6012 6016	Mice
T89	Endpoint 6131 6144	blood glucose
T90	EndpointUnitOfMeasure 6145 6159	concentrations
T91	TimeEndpointAssessed 6183 6188;6222 6249	0 min min after insulin injection
T92	TimeEndpointAssessed 6194 6196;6222 6249	15 min after insulin injection
T93	TimeEndpointAssessed 6198 6200;6222 6249	30 min after insulin injection
T94	TimeEndpointAssessed 6202 6204;6222 6249	45 min after insulin injection
T95	TimeEndpointAssessed 6206 6208;6222 6249	60 min after insulin injection
T96	TimeEndpointAssessed 6210 6212;6222 6249	90 min after insulin injection
T97	TimeEndpointAssessed 6218 6221;6222 6249	120 min after insulin injection
T98	Sex 6772 6776	mice
T99	Species 7155 7159	mice
T100	Endpoint 7664 7684	β-cell proliferation
T101	TimeEndpointAssessed 7845 7849	1DPN
T102	Endpoint 6621 6629;6645 6652	pancreas weighed
T103	Endpoint 6621 6629;6668 6688	pancreas immunohistochemistry
T104	Endpoint 6892 6906;7051 7071	soleus muscles immunohistochemistry
T105	Endpoint 7122 7142	β-cell proliferation
T106	GroupName 7485 7494	N1D group
T107	TimeEndpointAssessed 7562 7566	1DPN
T108	Endpoint 9083 9108;9116 9126	morphological examination pancreases
T109	Endpoint 9237 9248	β-cell mass
T110	EndpointUnitOfMeasure 9250 9273	milligrams per pancreas
T111	Endpoint 9458 9469	β-cell size
T112	Endpoint 9619 9643	relative insulin content
T113	Endpoint 9781 9801	β-cell proliferation
T114	EndpointUnitOfMeasure 9922 10007	ratio of insulin/BrdU double-positive cells to total insulin-positive cells in islets
T115	Endpoint 10215 10237	relative GLUT4 content
T116	Endpoint 10042 10047;10068 10097	level glucose transporter 4 (GLUT4)
T117	Endpoint 10052 10097	distribution of glucose transporter 4 (GLUT4)
T118	EndpointUnitOfMeasure 10283 10337	average intensity of GLUT4 immunofluorescence per cell
T119	Endpoint 10661 10683	protein concentrations
T120	Endpoint 11803 11823	serum corticosterone
T121	Endpoint 11776 11797	Corticosterone Levels
T122	EndpointUnitOfMeasure 12012 12041	nanograms/milliliter of serum
T123	Endpoint 12323 12334	β-cell size
T124	Endpoint 12340 12390	relative insulin fluorescence intensity in β cells
T125	Endpoint 12679 12686;12698 12711	insulin concentration
T126	Endpoint 12690 12711	glucose concentration
T127	GroupName 12942 12953	noise group
T128	GroupName 12962 12975	control group
T129	SampleSize 235 238	288
T130	Endpoint 2295 2312	insulin tolerance
T131	Endpoint 2266 2283	glucose tolerance
T132	TestArticleVerification 3719 3744;3753 3759;3761 3781;3794 3811	noise level was monitored 1/4-in (6.35 mm) microphone sound level meter
T133	TimeEndpointAssessed 4612 4617;4650 4684	0 min after an i.p. injection of glucose
T134	TimeUnits 4614 4617	min
T135	TimeEndpointAssessed 4623 4624;4650 4684	5 after an i.p. injection of glucose
T136	TimeEndpointAssessed 4626 4628;4650 4684	10 after an i.p. injection of glucose
T137	TimeEndpointAssessed 4630 4632;4650 4684	30 after an i.p. injection of glucose
T138	TimeEndpointAssessed 4634 4636;4650 4684	60 after an i.p. injection of glucose
T139	TimeEndpointAssessed 4642 4645;4650 4684	120 after an i.p. injection of glucose
T140	TimeUnits 4646 4649	min
T141	Endpoint 5093 5110	glucose tolerance
T142	Endpoint 5119 5135	insulin response
T143	Endpoint 5504 5537	fasting blood glucose level (FBG)
T144	Endpoint 5542 5575	fasting serum insulin level (FSI)
T145	GroupName 7614 7623	N1D group
T146	TimeEndpointAssessed 7627 7631	1DPN
